Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial
达沙替尼再次治疗慢性粒细胞白血病患者,在第二次尝试停用酪氨酸激酶抑制剂(TKI)后达到无治疗缓解——DAstop2试验的中期结果
期刊:Leukemia
影响因子:13.4
doi:10.1038/s41375-024-02145-6
Flygt, Hjalmar; Söderlund, Stina; Richter, Johan; Saussele, Susanne; Koskenvesa, Perttu; Stenke, Leif; Mustjoki, Satu; Dimitrijevic, Andreja; Stentoft, Jesper; Majeed, Waleed; Roy, Lydia; Wolf, Dominik; Dreimane, Arta; Gjertsen, Bjørn Tore; Gedde-Dahl, Tobias; Ahlstrand, Erik; Markevärn, Berit; Hjorth-Hansen, Henrik; Janssen, Jeroen; Olsson-Strömberg, Ulla